HEATHER HALLOWELL: Open Payments
NPI 1629745013 · CLACKAMAS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 27 payments from 9 companies in 2025. Trend: 2023 $839 · 2024 $669 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $232 |
| Regeneron Healthcare Solutions, Inc. | 13 | $224 |
| Janssen Biotech, Inc. | 2 | $131 |
| ABBVIE INC. | 3 | $66 |
| Lilly USA, LLC | 2 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $41 |
| UCB, Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Incyte Corporation | 1 | $19 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, SKYRIZI, TALTZ, ILUMYA, Bimzelx, RINVOQ.
Industry payments across OR — which companies pay providers there.
